Kalpesh Thakkar1, Hashem B El-Serag, Nora Mattek, Mark A Gilger. 1. Section of Pediatric Gastroenterology, Department of Hepatology and Nutrition, Texas Children's Hospital and Baylor College of Medicine, Houston, Texas 77030, USA.
Abstract
BACKGROUND: Available estimates of the incidence and type of complications during pediatric EGD are inconsistent. OBJECTIVE: To determine the frequency and the determinants of immediate complications during EGD in children. DESIGN: We conducted a cross-sectional database study. SETTING: The study involved 13 pediatric facilities that use the PEDS-CORI (Pediatric Endoscopy Database System Clinical Outcomes Research Initiative). PATIENTS: Children (0-18 years) who underwent EGD at 13 facilities between November 1999 and December 2003. MAIN OUTCOME MEASUREMENTS: We identified complications (recorded shortly after the procedure) and analyzed their occurrence with respect to procedure indication, American Society of Anesthesiologists (ASA) class, sex, age, anesthesia type, and unplanned interventions. RESULTS: We analyzed 10,236 procedures performed in 9234 patients. Immediate complications were reported in 239 procedures (2.3%, 95% confidence interval 2.0%-2.6%). The most common complications were hypoxia (157 [1.5%]) and bleeding (28 [0.3%]). Complication rates were significantly higher in the youngest age group, highest ASA class, female gender, intravenous (IV) sedation group, and in the presence of a fellow. LIMITATIONS: The study is limited by a lack of specific details and explicit criteria for reported complications. CONCLUSIONS: The overall immediate complication rate of pediatric EGD is 2.3%. All complications were nonfatal, and most were hypoxia related (157/239 [66%]) and reversible. Young age, higher ASA class, female sex, and IV sedation are risk factors for developing complications.
BACKGROUND: Available estimates of the incidence and type of complications during pediatric EGD are inconsistent. OBJECTIVE: To determine the frequency and the determinants of immediate complications during EGD in children. DESIGN: We conducted a cross-sectional database study. SETTING: The study involved 13 pediatric facilities that use the PEDS-CORI (Pediatric Endoscopy Database System Clinical Outcomes Research Initiative). PATIENTS: Children (0-18 years) who underwent EGD at 13 facilities between November 1999 and December 2003. MAIN OUTCOME MEASUREMENTS: We identified complications (recorded shortly after the procedure) and analyzed their occurrence with respect to procedure indication, American Society of Anesthesiologists (ASA) class, sex, age, anesthesia type, and unplanned interventions. RESULTS: We analyzed 10,236 procedures performed in 9234 patients. Immediate complications were reported in 239 procedures (2.3%, 95% confidence interval 2.0%-2.6%). The most common complications were hypoxia (157 [1.5%]) and bleeding (28 [0.3%]). Complication rates were significantly higher in the youngest age group, highest ASA class, female gender, intravenous (IV) sedation group, and in the presence of a fellow. LIMITATIONS: The study is limited by a lack of specific details and explicit criteria for reported complications. CONCLUSIONS: The overall immediate complication rate of pediatric EGD is 2.3%. All complications were nonfatal, and most were hypoxia related (157/239 [66%]) and reversible. Young age, higher ASA class, female sex, and IV sedation are risk factors for developing complications.
Authors: Mark Ram Borgaonkar; Lawrence Hookey; Roger Hollingworth; Ernst J Kuipers; Alan Forster; David Armstrong; Alan Barkun; Ron Bridges; Rose Carter; Chris de Gara; Catherine Dube; Robert Enns; Donald Macintosh; Sylviane Forget; Grigorios Leontiadis; Jonathan Meddings; Peter Cotton; Roland Valori Journal: Can J Gastroenterol Date: 2012-02 Impact factor: 3.522
Authors: Nathalie Nguyen; William J Lavery; Kelley E Capocelli; Clinton Smith; Emily M DeBoer; Robin Deterding; Jeremy D Prager; Kristina Leinwand; Greg E Kobak; Robert E Kramer; Calies Menard-Katcher; Glenn T Furuta; Dan Atkins; David Fleischer; Matthew Greenhawt; Joel A Friedlander Journal: Clin Gastroenterol Hepatol Date: 2019-01-29 Impact factor: 11.382